Investigation Overview
April 30, 2012 (Shareholders Foundation) -- An investigation on behalf of investors in Gen-Probe Incorporated (NASDAQ:GPRO) shares concerning whether the offer by Hologic, Inc to acquire Gen-Probe Incorporated at $82.75 per share and the buyout process are unfair to investors in NASDAQ:GPRO was announced. The investigation by a law firm concerns whether certain officers and directors...
You must register (for free) or login to view the entire investigation.